Literature DB >> 26867650

TGF-β triggers HBV cccDNA degradation through AID-dependent deamination.

Ying Qiao1, Xiaoxu Han2, Gefei Guan3, Na Wu1, Jianbo Sun4, Vladimir Pak5, Guoxin Liang2.   

Abstract

The covalently closed circular DNA (cccDNA) of hepatitis B virus (HBV) is a viral center molecule for HBV infection and persistence. However, the cellular restriction factors of HBV cccDNA are not well understood. Here, we show that TGF-β can induce nuclear viral cccDNA degradation and hypermutation via activation-induced cytidine deaminase (AID) deamination activity in hepatocytes. This suppression by TGF-β is abrogated when AID or the activity of uracil-DNA glycosylase (UNG) is absent, which indicates that AID deamination and the UNG-mediated excision of uracil act in concert to degrade viral cccDNA. Moreover, the HBV core protein promotes the interaction between AID and viral cccDNA. Overall, our results indicate a novel molecular mechanism that allows cytokine TGF-β to restrict viral nuclear cccDNA in innate immunity, thereby suggesting a novel method for potentially eliminating cccDNA.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  AID; HBV; Hypermutation; UNG; cccDNA

Mesh:

Substances:

Year:  2016        PMID: 26867650     DOI: 10.1002/1873-3468.12058

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

Review 1.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

Review 2.  Advanced Strategies for Eliminating the cccDNA of HBV.

Authors:  Jingwu Dong; Jie Ying; Xiaoyan Qiu; Yu Lu; Miaomiao Zhang
Journal:  Dig Dis Sci       Date:  2017-11-20       Impact factor: 3.199

3.  Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20.

Authors:  Daniela Stadler; Martin Kächele; Alisha N Jones; Julia Hess; Christian Urban; Jessica Schneider; Yuchen Xia; Andreas Oswald; Firat Nebioglu; Romina Bester; Felix Lasitschka; Marc Ringelhan; Chunkyu Ko; Wen-Min Chou; Arie Geerlof; Maarten A van de Klundert; Jochen M Wettengel; Peter Schirmacher; Mathias Heikenwälder; Sabrina Schreiner; Ralf Bartenschlager; Andreas Pichlmair; Michael Sattler; Kristian Unger; Ulrike Protzer
Journal:  EMBO Rep       Date:  2021-05-09       Impact factor: 8.807

Review 4.  Control of Hepatitis B Virus by Cytokines.

Authors:  Yuchen Xia; Ulrike Protzer
Journal:  Viruses       Date:  2017-01-20       Impact factor: 5.048

Review 5.  Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection.

Authors:  Ana Maria Ortega-Prieto; Marcus Dorner
Journal:  Vaccines (Basel)       Date:  2017-09-01

Review 6.  Circular RNAs: Regulators of Cancer-Related Signaling Pathways and Potential Diagnostic Biomarkers for Human Cancers.

Authors:  Zuozhang Yang; Lin Xie; Lei Han; Xin Qu; Yihao Yang; Ya Zhang; Zewei He; Yu Wang; Jing Li
Journal:  Theranostics       Date:  2017-07-22       Impact factor: 11.556

7.  Replenishment of Hepatitis B Virus cccDNA Pool Is Restricted by Baseline Expression of Host Restriction Factors In Vitro.

Authors:  Sergey Brezgin; Anastasiia Kostyusheva; Ekaterina Bayurova; Ilya Gordeychuk; Maria Isaguliants; Irina Goptar; Anastasiia Nikiforova; Valery Smirnov; Elena Volchkova; Dieter Glebe; Dmitry Kostyushev; Vladimir Chulanov
Journal:  Microorganisms       Date:  2019-11-06

Review 8.  Deaminase-Independent Mode of Antiretroviral Action in Human and Mouse APOBEC3 Proteins.

Authors:  Yoshiyuki Hakata; Masaaki Miyazawa
Journal:  Microorganisms       Date:  2020-12-12

9.  Alteration of microRNA profiles by a novel inhibitor of human La protein in HBV-transformed human hepatoma cells.

Authors:  Jiaqian Pan; Shuangmei Tong; Jing Tang
Journal:  J Med Virol       Date:  2017-09-22       Impact factor: 2.327

10.  An Immortalized Hepatocyte-like Cell Line (imHC) Accommodated Complete Viral Lifecycle, Viral Persistence Form, cccDNA and Eventual Spreading of a Clinically-Isolated HBV.

Authors:  Khanit Sa-Ngiamsuntorn; Piyanoot Thongsri; Yongyut Pewkliang; Adisak Wongkajornsilp; Pattida Kongsomboonchoke; Phichaya Suthivanich; Suparerk Borwornpinyo; Suradej Hongeng
Journal:  Viruses       Date:  2019-10-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.